Fig. 3
From: DDX1 is a prognostic biomarker and correlates with immune infiltrations in hepatocellular carcinoma
Genetic alteration and methylation of DDX1 in HCC. A OncoPrint visual summary of alteration in DDX1. B Summary of alterations in DDX1 in HCC based on three datasets. C, D Comparison of the survival prognosis between DDX1 mutation and unmutation groups. E Visualization of six CpG sites on DDX1 with methylation level. F–I Relation between DDX1 promoter methylation in HCC and normal tissues and clinicopathological characteristics: F normal versus primary tumor, G tumor grade, H TP53 mutation status, and I gender